Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873660 · ClinicalTrials.gov registry record
A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 5,360
- Enrollment target
NCT05873660: Completed study, sponsored by Novo Nordisk A/S.
NCT05873660 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 5,360 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05873660 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 5,360 participants
- Enrollment target
Study Summary
The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.
Primary Outcome
% of patients
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,360 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2024-06-24 |
What the finished NCT05873660 record still lists
NCT05873660 is an observational study that tracks outcomes without assigning an intervention. Its 5,360 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT05873660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05873660 about?
NCT05873660 is a clinical study titled "A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease". The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across ...
What is the current status of trial NCT05873660?
This trial is currently completed. The enrollment target is 5,360 participants. The study started on 2023-06-12. Estimated completion is 2024-06-24.
What interventions are being tested in trial NCT05873660?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT05873660?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05836987 · 5,350 participants · Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI